Commerzbank set a €53.00 ($61.63) price objective on Compugroup Medical (ETR:COP) in a report published on Thursday morning. The firm currently has a buy rating on the stock.

Several other research analysts have also weighed in on COP. Berenberg Bank set a €49.00 ($56.98) price objective on Compugroup Medical and gave the stock a neutral rating in a research report on Monday, July 16th. Baader Bank set a €46.00 ($53.49) price objective on Compugroup Medical and gave the stock a neutral rating in a research report on Monday, July 30th. Warburg Research set a €53.50 ($62.21) price objective on Compugroup Medical and gave the stock a buy rating in a research report on Friday, August 10th. Deutsche Bank set a €62.00 ($72.09) price objective on Compugroup Medical and gave the stock a buy rating in a research report on Tuesday, August 14th. Finally, Hauck & Aufhaeuser set a €36.00 ($41.86) price objective on Compugroup Medical and gave the stock a sell rating in a research report on Friday, August 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of €51.79 ($60.22).

Shares of Compugroup Medical stock opened at €46.14 ($53.65) on Thursday. Compugroup Medical has a fifty-two week low of €40.10 ($46.63) and a fifty-two week high of €60.30 ($70.12).

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

See Also: Short Selling Stocks and Day Traders

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.